Stocklytics Platform
Asset logo for symbol ERNA
Eterna Therapeutics
ERNA
35
$1.81arrow_drop_down1.64%-$0.03
Penny Stock

Performance History

Chart placeholder
Key Stats
Open$1.86
Prev. Close$1.85
EPS-4.25
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap10496041.00
PE Ratio-
LOWHIGH
Day Range1.80
1.95
52 Week Range0.84
2.99
Ratios
P/B Ratio5.43
Revenue-
Operating M. %-12,312.77%
Earnings$0.00
Earnings Growth %11.84%
EBITDA Margin %-
ROE %-1,154.18%
EPS-4.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$903.88
Perf. (24h)
arrow_drop_up1.54%$13.77
Market Cap$840.04B
Price$485.07
Perf. (24h)
arrow_drop_down1.00%-$4.90
Market Cap$451.00B
Price$147.41
Perf. (24h)
arrow_drop_down1.14%-$1.70
Market Cap$357.99B
Price$133.22
Perf. (24h)
arrow_drop_up0.19%$0.25
Market Cap$331.08B

About Eterna Therapeutics (ERNA)

Eterna Therapeutics Inc., a preclinical-stage, biopharmaceutical company. The company offers Synthetic mRNA, ToRNAdo mRNA Delivery, mRNA Gene Editing, and mRNA Cell Reprogramming. It also develops therapies and medicines using gene-editing proteins and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. The company was formerly known as Brooklyn ImmunoTherapeutics, Inc. and changed its name to Eterna Therapeutics Inc. in October 2022. Eterna Therapeutics Inc. is based in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Matthew Angel Ph.D.
Headquarters
Cambridge
Employees
9
Exchange
NASDAQ
add Eterna Therapeutics to watchlist

Keep an eye on Eterna Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Eterna Therapeutics's (ERNA) price per share?

The current price per share for Eterna Therapeutics (ERNA) is $1.82. The stock has seen a price change of -$0.03 recently, indicating a -1.64% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Eterna Therapeutics (ERNA)?

For Eterna Therapeutics (ERNA), the 52-week high is $2.99, which is 64.32% from the current price. The 52-week low is $0.84, the current price is 116.62% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Eterna Therapeutics (ERNA) a growth stock?

Eterna Therapeutics (ERNA) has shown an average price growth of 0.41% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eterna Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Eterna Therapeutics (ERNA) stock price performance year to date (YTD)?

As of the latest data, Eterna Therapeutics (ERNA) has a year-to-date price change of -3.21%. Over the past month, the stock has experienced a price change of -11.67%. Over the last three months, the change has been -23.51%. Over the past six months, the figure is -7.67%.

help
Is Eterna Therapeutics (ERNA) a profitable company?

Eterna Therapeutics (ERNA) has a net income of -$21.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -12.31K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$20.67M. Furthermore, the EBITDA is -$21.04M.

help
What is the market capitalization of Eterna Therapeutics (ERNA)?

Eterna Therapeutics (ERNA) has a market capitalization of $10.5M. The average daily trading volume is 4.96K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level